These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11683962)

  • 21. Generation of a novel decay accelerating factor (DAF) knock-out rat model using clustered regularly-interspaced short palindromic repeats, (CRISPR)/associated protein 9 (Cas9), genome editing.
    Detsika MG; Goudevenou K; Geurts AM; Gakiopoulou H; Grapsa E; Lianos EA
    Transgenic Res; 2021 Feb; 30(1):11-21. PubMed ID: 33387103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of decay accelerating factor in the immunopathogenesis of cytomegalovirus infection.
    Bani-Ahmad M; El-Amouri IS; Ko CM; Lin F; Tang-Feldman Y; Oakley OR
    Clin Exp Immunol; 2011 Feb; 163(2):199-206. PubMed ID: 21166665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
    Lublin DM; Coyne KE
    J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).
    Karnauchow TM; Tolson DL; Harrison BA; Altman E; Lublin DM; Dimock K
    J Virol; 1996 Aug; 70(8):5143-52. PubMed ID: 8764022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats.
    Pérez de la Lastra JM; Harris CL; Hinchliffe SJ; Holt DS; Rushmere NK; Morgan BP
    J Immunol; 2000 Sep; 165(5):2563-73. PubMed ID: 10946283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse decay-accelerating factor: selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form.
    Song WC; Deng C; Raszmann K; Moore R; Newbold R; McLachlan JA; Negishi M
    J Immunol; 1996 Nov; 157(9):4166-72. PubMed ID: 8892654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF.
    Li B; Sallee C; Dehoff M; Foley S; Molina H; Holers VM
    J Immunol; 1993 Oct; 151(8):4295-305. PubMed ID: 7691944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease.
    Lin F; Spencer D; Hatala DA; Levine AD; Medof ME
    J Immunol; 2004 Mar; 172(6):3836-41. PubMed ID: 15004190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice.
    Pritchard MT; McMullen MR; Stavitsky AB; Cohen JI; Lin F; Edward Medof M; Nagy LE
    Gastroenterology; 2007 Mar; 132(3):1117-1126. PubMed ID: 17383432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and functional analysis of mouse decay accelerating factor (CD55).
    Harris CL; Rushmere NK; Morgan BP
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):821-9. PubMed ID: 10417349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities.
    Harris CL; Spiller OB; Morgan BP
    Immunology; 2000 Aug; 100(4):462-70. PubMed ID: 10929073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.
    Bergelson JM; Chan M; Solomon KR; St John NF; Lin H; Finberg RW
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6245-8. PubMed ID: 7517044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.
    Miwa T; Sato S; Gullipalli D; Nangaku M; Song WC
    J Immunol; 2013 Apr; 190(7):3552-9. PubMed ID: 23427256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A monoclonal antibody against human decay-accelerating factor (DAF, CD55), D17, which lacks reactivity with semen-DAF.
    Hara T; Matsumoto M; Fukumori Y; Miyagawa S; Hatanaka M; Kinoshita T; Seya T; Akedo H
    Immunol Lett; 1993 Aug; 37(2-3):145-52. PubMed ID: 7505002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production.
    Lalli PN; Strainic MG; Lin F; Medof ME; Heeger PS
    J Immunol; 2007 Nov; 179(9):5793-802. PubMed ID: 17947652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo.
    Liu J; Miwa T; Hilliard B; Chen Y; Lambris JD; Wells AD; Song WC
    J Exp Med; 2005 Feb; 201(4):567-77. PubMed ID: 15710649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decay-accelerating factor prevents acute humoral rejection induced by low levels of anti-alphaGal natural antibodies.
    Shimizu I; Smith NR; Zhao G; Medof E; Sykes M
    Transplantation; 2006 Jan; 81(1):95-100. PubMed ID: 16421483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of DAF in protecting against T-cell autoreactivity that leads to experimental autoimmune uveitis.
    An F; Li Q; Tu Z; Bu H; Chan CC; Caspi RR; Lin F
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3778-82. PubMed ID: 19443714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
    Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decay-accelerating factor in guinea pig stomachs following ischemia reperfusion stress.
    Oshima T; Okada N; Joh T; Sasaki M; Tada T; Matsukawa N; Nomura T; Ohara H; Itoh M; Okada H
    J Immunol; 2000 Jan; 164(2):1078-85. PubMed ID: 10623859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.